The FLOW study highlights the risks of CKD progression, cardiovascular disease and death in those with type 2 diabetes and CKD, and the significant benefits of the pillars of treatment: ACE inhibitors/ARBs, SGLT2 inhibitors, finerenone and, now, semaglutide
Curr Pharm Des 16(26):29182928 Shi S, Chen Y, Luo Z, Nie G, Dai Y (2023) Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Lifestyle Adjustments to Manage GLP-1 Side Effects Beyond dietary modifications, several lifestyle strategies can help minimise bloating and improve overall tolerance of GLP-1 medications
It's a measurement of how fast the battery releases power
PT-141, also known as bremelanotide, is a peptide therapy designed to improve low sexual desire and arousal in men